Shire, a biotech company focused on developing breakthrough therapies for rare diseases and high-need conditions, has agreed to license global rights to Pfizer’s new gastrointestinal drug. PF-00547659 ...

Gastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcomes. The drug adagrasib specifically targets the KRASG12C gene ...

Readouts in hepatocellular carcinoma, as well as pancreatic, gastric and salivary gland cancer, are capturing attention at ...

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...

Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical ...

Using jet propulsion inspired by squid, researchers demonstrate a microjet system that delivers medications directly into tissues, matching the effectiveness of traditional needles. Study: ...

Microjet delivery systems that are inspired by cephalopods’ propulsion methods enable the needle-free administration of large biomolecules through the lining of the gastrointestinal tract. These ...

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella ...

Ozempic, the prescription diabetes drug that has taken over as one of the top weight loss methods, has some interesting potential side effects. While there have been Ozempic fakes popping up and even ...